Literature DB >> 26085722

Joint Health Status of Hemophilia Patients in Jodhpur Region.

Vikas Payal1, Pramod Sharma1, N P Chhangani1, Yojana Janu2, Yudhavir Singh1, Akash Sharma1.   

Abstract

Hemophilia refers to a group of bleeding disorders in which there is a deficiency of one of the factors necessary for coagulation of the blood. Susceptibility to joint hemorrhage in persons with Hemophilia suggests that the routine assessment of joint health is an important aspect of clinical management and outcome studies assessing the efficacy of treatment. This prospective study was conducted to study joint health status in Hemophilia patients and draw their joint disability score by using Hemophilia Joint Health Score (HJHS). Out of total 56 cases 51 (91.07 %) cases were diagnosed as hemophilia A while 5 cases (8.92 %) were diagnosed as hemophilia B. According to their factor level 44 % cases had severe 36 % had moderate and 20 % had mild disease. Knee joint was the predominant joint affected by hemarthrosis in 67.85 % cases followed by ankle joint (51.7 %) elbow joint (35.7 %), hip joint (12.5 %), shoulder joint (5.3 %) and proximal metacarpophalangeal joint (1.78 %).Out of total 37.5 % patients of hemophilia had developed target joint. Knee joint was the predominant target joint in 28.57 % cases and ankle joint was the target joint in 8.92 % cases. Maximum number of patients (40.47 %) had HJHS score of zero. The mean HJHS score was 6.78 ± 9.04. HJHS score showing significant positive correlation with age of patient (p < 0.0001). Most risky period and most aggravating development of hemophilic joint damage starts from 7 years of age. Therefore, treatment decisions, such as starting prophylaxis, should be tailored according to bleeding pattern and age of patients rather than based on the clotting factor activity levels.

Entities:  

Keywords:  Heamarthrosis; Hemophilia joint health score; Target joint

Year:  2014        PMID: 26085722      PMCID: PMC4465520          DOI: 10.1007/s12288-014-0465-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  8 in total

Review 1.  The hemophilias--from royal genes to gene therapy.

Authors:  P M Mannucci; E G Tuddenham
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

2.  Christmas disease: a condition previously mistaken for haemophilia.

Authors:  R BIGGS; A S DOUGLAS; R G MACFARLANE; J V DACIE; W R PITNEY
Journal:  Br Med J       Date:  1952-12-27

3.  Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study.

Authors:  S Ota; M Mclimont; M D Carcao; V S Blanchette; N Graham; E Paradis; B M Feldman
Journal:  Haemophilia       Date:  2007-01       Impact factor: 4.287

4.  The knee joint in hemophilia.

Authors:  J E Handelsman
Journal:  Orthop Clin North Am       Date:  1979-01       Impact factor: 2.472

5.  Prophylaxis: musculoskeletal evaluation.

Authors:  M S Gilbert
Journal:  Semin Hematol       Date:  1993-07       Impact factor: 3.851

6.  Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia.

Authors:  A Christoforidis; M Economou; E Papadopoulou; E Kazantzidou; E Farmaki; V Tzimouli; I Tsatra; N Gompakis; M Athanassiou-Metaxa
Journal:  Haemophilia       Date:  2010-09-02       Impact factor: 4.287

Review 7.  Haemophilias A and B.

Authors:  Paula H B Bolton-Maggs; K John Pasi
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

8.  Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania.

Authors:  S Saulyte Trakymiene; J Ingerslev; L Rageliene
Journal:  Haemophilia       Date:  2010-01-12       Impact factor: 4.287

  8 in total
  2 in total

1.  Effect of Prophylactic Management of Hemophilia on Bleeding Episodes.

Authors:  Suman Roy; Arun Kumar De
Journal:  Indian J Hematol Blood Transfus       Date:  2018-12-03       Impact factor: 0.900

2.  Evaluation of quality of life in hemophilia patients using the WHOQOL-bref and Haemo-A-Qol questionnaires.

Authors:  Gustavo Cambraia Trindade; Luíza Gabrielle de Lacerda Viggiano; Enderson Resende Brant; Carlos Alexandre de Oliveira Lopes; Mateus Lopes de Faria; Pedro Henrique Nery de Sá Ribeiro; Ana Flávia do Carmo Silva; Diana Maria de Resende Souza; Aline de Freitas Lopes; João Marcos Arantes Soares; Melina de Barros Pinheiro
Journal:  Hematol Transfus Cell Ther       Date:  2019-07-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.